Suicidal Attacks in Children and Adolescents
Launched by ASSIUT UNIVERSITY · Sep 26, 2023
Trial Information
Current as of November 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Suicidal Attacks in Children and Adolescents," aims to better understand the behaviors associated with suicide attempts among young people at Assiut University Children Hospital. The researchers want to identify the most common causes and risk factors that lead to these attempts, as well as the methods and circumstances involved. They also plan to estimate how often these incidents occur in children and adolescents at the hospital.
To participate in this study, children aged 5 to 18 years who have previously attempted suicide will be eligible. Unfortunately, the trial will not include adults or children who have tried to harm themselves using specific methods like gunshots or falls from heights. If you or someone you know is eligible, participants can expect to share their experiences and help researchers gather important information that could improve support for young people facing similar challenges. It's important to note that this trial is not yet recruiting participants, so there will be more information available as it progresses.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All children between the ages of 5-18 years, with at least history of one suicidal attempt.
- Exclusion Criteria:
- • • Adult population and don't include children and adolescents as participants. Children and adolescents committing suicide by gunshots and falling from height.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Khalaf Abd El-Aal Sayed, Dr
Study Director
Assiut University
Emad El-Deen Mohamoud, Dr
Principal Investigator
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported